drugset / Trial / NCT00236327
Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and efficacy of pain control by fentanyl, administered via adhesive skin patches, at doses of 25 to 100 micrograms per hour in 80 out-patients with intense chronic cancer pain. Higher doses are allowed by permission of the investigator and rescue oral morphine medication is allowed.
Timeline
- Start
- 2003-06
- Primary completion
- —
- Completion
- 2004-05
Outcome
Outcome not reported
Stopped: “Sponsor discontinued the study following the discovery of a number of incompletely sealed batches that were unusable.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | 25 ug | Other |
| Subject | Fentanyl | Other / unclassified | 100 ug | Other |
Indications
No indication recorded.